Curis | CRIS - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Alaunos Therapeutics USD -1.01M 175K 2026-03
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 827M 2.7B 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
CSL USD 2.64B 1.97B 2025-12
Curis USD -11.52M 3.64M 2026-03
Eli Lilly USD 12.46B 2.68B 2026-06
Exelixis USD 248.41M 2.93M 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Merck USD 840M 2.72B 2026-06
Novartis USD 4.75B 515M 2026-06
Pfizer USD 667M 4.32B 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
Takeda JPY 201.42B 215.04B 2026-06
TG Therapeutics USD 21.67M 13.12M 2026-06
Verastem USD -44.9M 3.42M 2026-03